Trexquant Investment LP Tricida, Inc. Transaction History

Trexquant Investment LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$4.52 - $7.8 $149,259 - $257,571	-33,022 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$4.37 - $9.46 $8,652 - $18,730	1,980 Added 6.38%	33,022 $233,000
Q3 2020 Nov 06, 2020	BUY	$8.56 - $26.93 $137,233 - $431,741	16,032 Added 106.81%	31,042 $281,000
Q2 2020 Aug 07, 2020	BUY	$21.21 - $31.55 $318,362 - $473,565	15,010 New	15,010 $412,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.